The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

COVID-19 indicators have fallen to their lowest levels since early summer 2024 after very low levels that spring. Cases and ...

As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

As of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended ...